var data={"title":"Noma (cancrum oris)","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Noma (cancrum oris)</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/contributors\" class=\"contributor contributor_credentials\">Cyril O Enwonwu, ScD, PhD, MDS, BDS</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/contributors\" class=\"contributor contributor_credentials\">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 15, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Noma is a severe disfiguring gangrene of the mouth and face that begins as a gingival ulcer and spreads rapidly through the tissues of the mouth and face [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/1-5\" class=\"abstract_t\">1-5</a>]. Unlike other infectious processes of the face, which may progress along anatomic spaces of the head and neck, noma can disrupt anatomic barriers and spread through muscle and bone [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/4\" class=\"abstract_t\">4</a>]. The resulting gangrene may involve the maxilla, the mandible, and extend to the nose and infraorbital margins (<a href=\"image.htm?imageKey=ID%2F70829\" class=\"graphic graphic_picture graphicRef70829 \">picture 1</a>). The word noma derives from the Greek &quot;voun,&quot; meaning to devour, emphasizing the rapid progression of the disease [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,7\" class=\"abstract_t\">6,7</a>].</p><p>Noma is categorized by the World Health Organization (WHO) as a necrotizing ulcerative stomatitis. Synonyms include cancrum oris and fusospirochetal gangrene. The name &quot;cancrum oris&quot; was introduced in Britain in the mid-17<sup>th</sup> century and is still in common usage in the United Kingdom [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/7,8\" class=\"abstract_t\">7,8</a>]. According to an 1848 description, orofacial noma is a &quot;gangrenous affection of the mouth, especially attacking children in whom the constitution is altered by bad hygiene and serious illness, especially from the eruptive fevers, beginning as an ulcer of the mucous membrane, with edema of the face, extending from within out, rapidly destroying the soft parts and the bone, and almost always quickly fatal&quot; [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/9\" class=\"abstract_t\">9</a>].</p><p>Mortality due to noma can be reduced with prompt, appropriate treatment. Noma is one of the most devastating and disfiguring human diseases worldwide and has been designated a health priority by the WHO [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,10-13\" class=\"abstract_t\">3,10-13</a>].</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Noma is a polymicrobial infection associated predominantly with anaerobic organisms [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,14\" class=\"abstract_t\">3,14</a>]. <em>Fusobacterium necrophorum</em> has been observed most frequently in culture and appears to be an important organism for the development of noma [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/15-18\" class=\"abstract_t\">15-18</a>]. Virulence factors of <em>F. necrophorum</em> include proteolytic enzymes and toxins capable of tissue destruction [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/18\" class=\"abstract_t\">18</a>]. <em>F. necrophorum</em> also produces a growth stimulating factor for <em>Prevotella intermedia</em>, which facilitates lipid degradation.</p><p>Other microorganisms cultivated from noma lesions among Nigerian children are similar to those seen in adult periodontitis and are also capable of releasing enzymes that can degrade host tissues [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/19\" class=\"abstract_t\">19</a>]. These include <em>P. intermedia</em>, alpha-hemolytic streptococci, <em>Pseudomonas</em> spp, <em>Actinomyces</em> spp, and <em>Peptostreptococcus micros</em> [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,15-18,20-22\" class=\"abstract_t\">3,15-18,20-22</a>]. Spirochetes have also been observed at the advancing edge of active lesions with dark-field microscopy [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/15\" class=\"abstract_t\">15</a>]. Molecular studies have demonstrated the complex diversity of microorganisms associated with noma, including 67 bacterial species, of which 25 have not yet been grown in vitro [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/23\" class=\"abstract_t\">23</a>]. Herpes viruses have also been implicated, particularly herpes simplex virus and cytomegalovirus [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/1,21,24-26\" class=\"abstract_t\">1,21,24-26</a>].</p><p>Development of noma has been attributed to an imbalance of oral bacterial flora in some studies, noting reduced bacterial diversity and a prominently increased proportion of organisms in the <em>Prevotella</em> genus [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/27,28\" class=\"abstract_t\">27,28</a>]. One study in the Niger Republic observed larger counts of <em>P. intermedia</em> and members of the <em>Peptostreptococcus</em> genus in noma lesions than in non-noma cases [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/27\" class=\"abstract_t\">27</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The global distribution of noma is poorly understood. Many affected individuals die in the acute stage of the disease before presenting for clinical attention; most reside in rural areas, and some hide deliberately because of the stigma associated with the disease [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,10,29\" class=\"abstract_t\">3,10,29</a>]. It is estimated that only about 10 percent of patients seek care during the acute stage of illness [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/2,6,10,13,29,30\" class=\"abstract_t\">2,6,10,13,29,30</a>]. Infants and children are particularly susceptible.</p><p>The incidence of noma is highest in sub-Saharan Africa; the disease also occurs in Asia and Latin America [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/7,10,13,29,31-33\" class=\"abstract_t\">7,10,13,29,31-33</a>]. The World Health Organization estimates the global incidence of noma to be around 100,000 to 140,000 new cases per year [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/34\" class=\"abstract_t\">34</a>]. In countries such as Gambia, Niger, Nigeria, and Senegal, the annual incidence of noma based on hospital records ranges from 0.28 to 1.9 per 1000 children [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/29,35,36\" class=\"abstract_t\">29,35,36</a>]. In West Africa, the peak age range for acute illness is one to six years, although late stages do occur in adolescents and adults [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,6,7,10,37\" class=\"abstract_t\">3,6,7,10,37</a>]. The fatality rate in the absence of treatment is about 80 percent [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/34\" class=\"abstract_t\">34</a>]. With appropriate treatment, mortality rates are less than 10 percent [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,10\" class=\"abstract_t\">6,10</a>].</p><p>The <span class=\"nowrap\">HIV/AIDS</span> epidemic has been associated with an increase in the number of noma cases in developing and developed countries [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/1,8,38,39\" class=\"abstract_t\">1,8,38,39</a>]. Among 48 patients with noma seen at the University of Zimbabwe between 2002 and 2006, all were seropositive for HIV [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/40\" class=\"abstract_t\">40</a>].</p><p>Noma occurred worldwide until the early 20<sup>th</sup> century, when it essentially disappeared from the developed countries; some cases occurred in concentration camps during World War II [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/41,42\" class=\"abstract_t\">41,42</a>]. The near eradication of noma from developed countries coincided with improvements in living standards, prior to the discovery of penicillin [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/2,7,10\" class=\"abstract_t\">2,7,10</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Poverty is a critical risk factor for noma [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/1,7,37,43\" class=\"abstract_t\">1,7,37,43</a>]. Additional associated factors include malnutrition, poor sanitation, poor oral hygiene, limited access to healthcare services, close residential proximity to livestock, nomadic lifestyle, and residence in an area with high prevalence of infectious diseases including malaria, measles, AIDS, diarrhea, and tuberculosis [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,10,25,43\" class=\"abstract_t\">3,10,25,43</a>]. Infants and children are particularly susceptible. Noma does not appear to be a transmissible disease in humans; cases have not been reported in caregivers of children with the disease.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Malnutrition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chronic malnutrition is common in communities at risk for noma, as it increases susceptibility to infection [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,17,29,37,44\" class=\"abstract_t\">3,17,29,37,44</a>]. Nigerian studies have noted reductions in plasma levels of micronutrients (particularly retinol, ascorbate, and zinc) among children with noma compared with children without noma [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/27,31\" class=\"abstract_t\">27,31</a>]. These observations may reflect an acute phase response associated with infections that accompany nutritional deficiency states [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/45\" class=\"abstract_t\">45</a>].</p><p>Chronic malnutrition has been associated with increased numbers of mouth anaerobes (particularly <em>P. intermedia) </em>among malnourished children in Nigeria compared with well-nourished children, regardless of presence of overt oral pathology [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/46\" class=\"abstract_t\">46</a>].</p><p>Malnutrition is often intergenerational, commencing prenatally in the setting of poor maternal health during pregnancy [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/1,3,37\" class=\"abstract_t\">1,3,37</a>]. The developing immune system is influenced by malnutrition during the prenatal period [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,47-50\" class=\"abstract_t\">3,47-50</a>]. In communities at risk for noma, the prevalence of intrauterine growth retardation leading to infants who are small for gestational age (SGA) is high; in such settings, the infant mortality rate may be as high as 114 per 1000 live births [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/37,51,52\" class=\"abstract_t\">37,51,52</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Acute necrotizing gingivitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute necrotizing gingivitis (ANG) is an important risk condition for noma. ANG is characterized by ulceration involving one or more interdental papillae, pain, fetid breath, bad taste, fever, and lymphadenopathy (<a href=\"image.htm?imageKey=ID%2F64614\" class=\"graphic graphic_picture graphicRef64614 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/26,53,54\" class=\"abstract_t\">26,53,54</a>]. The most common sites of ANG are the premolar and molar area, followed by the mandibular incisor area. Ulceration of the overlapping inner cheek may also occur.</p><p>In sub-Saharan Africa, ANG typically occurs among malnourished children two to six years of age. The prevalence ranges from 2 to 18 percent in some rural communities [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,10,29,55\" class=\"abstract_t\">3,10,29,55</a>]. In developed settings, ANG is rare; it is occasionally observed in severely immunocompromised individuals such as patients with HIV infection and those receiving organ transplants [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/26,53,56\" class=\"abstract_t\">26,53,56</a>].</p><p>As with noma, ANG is likely attributable to periodontal bacteria and herpesviruses [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/24,57,58\" class=\"abstract_t\">24,57,58</a>]. Molecular studies support the hypothesis that ANG may be a precursor of noma [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/59\" class=\"abstract_t\">59</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Other factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Additional risk factors for noma include antecedent infections (particularly measles and malaria) and immunosuppressing conditions.</p><p>Measles infection alters cytokine activity, leading to immunosuppression that can persist up to six months after acute infection [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/60-63\" class=\"abstract_t\">60-63</a>]. Some have suggested that measles infection promotes development of acute noma in poor African children [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/1,6,10,25,64\" class=\"abstract_t\">1,6,10,25,64</a>]. Studies in the Congo Republic (formerly Zaire) have noted noma-like oral ulcerations following measles in severely malnourished children one to six years of age [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/25\" class=\"abstract_t\">25</a>]. The prolonged immunosuppressive effects elicited by measles infection compromise overall immunity [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/65\" class=\"abstract_t\">65</a>]; for example, stomatitis resulting from measles infection may promote reactivation of latent herpes viruses, resulting in peribuccal, perinasal, and infraorbital ulcerative lesions [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/25,64,66,67\" class=\"abstract_t\">25,64,66,67</a>].</p><p>Acute noma has been described in association with malaria infection in children [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/2,39,43,68\" class=\"abstract_t\">2,39,43,68</a>]. Malaria infection is associated with profound immune impairment [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/69-72\" class=\"abstract_t\">69-72</a>]. Effects of placental malaria include impaired utero-placental blood flow as well as reduced transplacental transfer of maternal antibodies to infectious diseases such as measles [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/73-76\" class=\"abstract_t\">73-76</a>].</p><p>Noma is reported in the following circumstances (see <a href=\"topic.htm?path=periodontal-disease-in-children-associated-systemic-conditions\" class=\"medical medical_review\">&quot;Periodontal disease in children: Associated systemic conditions&quot;</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HIV <span class=\"nowrap\">infection/AIDS</span> [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/40,77-79\" class=\"abstract_t\">40,77-79</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Type 2 diabetes mellitus [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/80\" class=\"abstract_t\">80</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immune-deficient states such as familial neutropenia, histiocytosis syndromes, and severe combined immunodeficiency (SCID) [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/20,81-85\" class=\"abstract_t\">20,81-85</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immunosuppressive therapy [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/86\" class=\"abstract_t\">86</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autoimmune diseases in the absence of immunosuppressive therapy [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/81\" class=\"abstract_t\">81</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypophosphatasia (an inborn error of metabolism caused by deficiency of tissue-nonspecific alkaline phosphatase) [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/83\" class=\"abstract_t\">83</a>]</p><p/><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">CLINICAL MANIFESTATIONS AND DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of noma is based on clinical manifestations. Suggestive clues include recent or concurrent infection preceding onset of facial swelling and excessive salivation in the setting of malnutrition. In general, there are three stages of noma (which may overlap): an acute phase, a gangrenous phase, and a scarring phase [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/4,7,10,18\" class=\"abstract_t\">4,7,10,18</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Acute phase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Symptoms associated with the acute phase of noma include mouth soreness, facial swelling, fetid breath, excessive salivation, and difficulty eating [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,10,11\" class=\"abstract_t\">6,10,11</a>]. The medical history is frequently notable for recent or concurrent infections such as diarrheal illness, malaria, measles, tuberculosis, or HIV [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,7,10,24,87\" class=\"abstract_t\">3,7,10,24,87</a>].</p><p>In general, children with acute noma are malnourished, as evidenced by growth retardation, hair discoloration, <span class=\"nowrap\">and/or</span> limb edema [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/2,25\" class=\"abstract_t\">2,25</a>]. In one study of Nigerian children &lt;4 years of age with acute noma, about 90 percent had stunted growth and were underweight; more than two-thirds were severely affected [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/37\" class=\"abstract_t\">37</a>]. Among age- and sex-matched neighborhood children without noma, about 40 percent were stunted and underweight; less than one-third were severely affected [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/37\" class=\"abstract_t\">37</a>].</p><p>Laboratory findings may include severe anemia (hemoglobin levels as low as 5 to 6 <span class=\"nowrap\">g/dL),</span> white blood cell counts of 20,000 to 30,000 per microL, and hypoalbuminemia [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/2,25,88\" class=\"abstract_t\">2,25,88</a>]. Anemia is often most severe among the most stunted children with noma.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Gangrenous phase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Noma likely begins as a gingival inflammatory lesion that spreads to the labiogingival fold and then to the mucosal surface of the cheek and lip [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/2,6\" class=\"abstract_t\">2,6</a>]. Subsequently, an area of bluish-black discoloration may appear on the cheek (<a href=\"image.htm?imageKey=ID%2F70829\" class=\"graphic graphic_picture graphicRef70829 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,30\" class=\"abstract_t\">6,30</a>]. After this finding, progression of the disease resulting in perforation of the cheek is very rapid (usually a matter of days) [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/1,2,6,30\" class=\"abstract_t\">1,2,6,30</a>]. During this time, there is extensive intraoral destruction (<a href=\"image.htm?imageKey=ID%2F62639\" class=\"graphic graphic_picture graphicRef62639 \">picture 3</a>). Soft tissue sloughing leaves a well-demarcated deep wound with exposed bones and teeth. Ulcerative gingivitis or periodontitis is considered to have progressed to noma once there is exposure of the alveolar bone [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/2,66\" class=\"abstract_t\">2,66</a>].</p><p>The disease is usually unilateral but can occur bilaterally. Some cases may occur with ectopic lesions involving the scalp, neck, shoulders, perineum, and vulva [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,89\" class=\"abstract_t\">6,89</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Scarring phase</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Scarring sets in following the acute and gangrenous stages, leading to trismus and severe facial disfigurement [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/30,63,77\" class=\"abstract_t\">30,63,77</a>]. Sequelae of noma depend on the sites affected and the extent of tissue destruction; they may include displacement or exfoliation of teeth, facial mutilation, bony fusion between the maxilla and mandible, trismus, poor speech, and difficulty feeding [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,30,63\" class=\"abstract_t\">6,30,63</a>]. Persistent leakage of saliva is a major problem in patients with extensive destruction of the maxilla, lower lip, cheek, <span class=\"nowrap\">and/or</span> floor of the mouth [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3,6\" class=\"abstract_t\">3,6</a>].</p><p>Trismus refers to limited mobility of the mandible. In the setting of noma, trismus may occur following necrosis of the mandible, which may be associated with dense scarring of the posterior part of the lining of the cheek, just anterior to the temporomandibular joint (TMJ). In some cases, bony fusion may occur between the mandible and maxilla. Patients with moderate to severe trismus (mouth aperture less than half of normal) may be associated with intubation difficulty as well as impairments of speech and feeding following surgery.</p><p>If possible, patients with trismus should be evaluated with radiographs of the mouth, skull (including the TMJ) and chest, in addition to blood counts. The extent of tissue defects may be evaluated using the classification system in the Table (<a href=\"image.htm?imageKey=ID%2F108387\" class=\"graphic graphic_table graphicRef108387 \">table 1</a>) to plan for surgery [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/63,90\" class=\"abstract_t\">63,90</a>]. (See <a href=\"#H21\" class=\"local\">'Surgical repair'</a> below.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of noma is not fully understood. The following sections summarize observed findings [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Histopathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Histopathology generally demonstrates necrosis of the epidermis with acanthosis around the rim of the epithelium [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/4,30,86\" class=\"abstract_t\">4,30,86</a>]. The necrotic area is well circumscribed; at the margins, there is hyperplasia with ballooning of the epithelial cells. The dermis typically has a heavy infiltrate of polymorphonuclear neutrophils; phagocytosed bacteria may be observed. Separation of collagen bundles due to edema may be observed. Blood vessels are frequently dilated and filled with inflammatory cells. Small and large cocci of various morphologies and gram-negative coccobacilli may be seen.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Role of malnutrition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Noma is associated with very low levels of most essential amino acids and significant reductions in plasma levels of vitamin A, vitamin C, zinc, albumin, and hemoglobin [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/17,25,31,47,88,91-93\" class=\"abstract_t\">17,25,31,47,88,91-93</a>]. Given the frequency of multiple concurrent deficiencies, no single nutrient deficiency has been causally related.</p><p>Leptin, a polypeptide produced by adipose tissue involved in the inflammatory response and immune function, is significantly diminished in children with noma [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/94-97\" class=\"abstract_t\">94-97</a>]. The prolonged inflammatory response in the setting of noma may downregulate or exhaust leptin production; similar observations have been described in the setting of tuberculosis with associated wasting and chronic inflammation [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/98\" class=\"abstract_t\">98</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Inflammatory mediators</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children with noma have higher inflammatory cytokine levels than neighborhood village children without noma; both groups have higher levels than age-matched healthy urban children [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/17\" class=\"abstract_t\">17</a>]. In the setting of noma, there appears to be disruption of complex interactions involving tumor necrosis factor (TNF) and the TNF family receptor herpes virus entry mediator (HVEM), leading to T cell stimulation and promotion of mucosal inflammation [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/99-101\" class=\"abstract_t\">99-101</a>].</p><p>The circulating cytokine patterns observed in children with noma and acute necrotizing gingivitis resemble findings in other diseases characterized by necrotic lesions [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/17\" class=\"abstract_t\">17</a>]. Increased systemic concentrations of cytokines (particularly TNF and interleukin-18) are also features of inflammatory bowel disease as well as measles, malaria, and sepsis [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/14,102-110\" class=\"abstract_t\">14,102-110</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of noma is straightforward in the gangrenous stage [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/111\" class=\"abstract_t\">111</a>]. The disease is readily recognized by the rapid course of inflammation in the setting of antecedent infection (measles, malaria, tuberculosis, etc). Diseases with similar characteristics include (see related topics):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Noma neonatorum resembles noma in children but occurs during the first few weeks of life in premature and low birthweight infants [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/112-115\" class=\"abstract_t\">112-115</a>]. The gangrene generally involves the oronasal region, eyelids, and perineum. Cultures may demonstrate <em>Pseudomonas aeruginosa</em>, <em>Escherichia coli</em>, <em>Klebsiella</em> spp, or staphylococci.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ecthyma gangrenosum &ndash; Ecthyma gangrenosum refers to a necrotic skin lesion associated with <em>P. aeruginosa</em> infection that may involve the oral cavity, nose, or perineum. Ecthyma gangrenosum resembles noma histopathologically [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/116\" class=\"abstract_t\">116</a>]. The diagnosis of ecthyma gangrenosum is established based on clinical manifestations and culture results. (See <a href=\"topic.htm?path=pseudomonas-aeruginosa-skin-and-soft-tissue-infections#H1133434152\" class=\"medical medical_review\">&quot;Pseudomonas aeruginosa skin and soft tissue infections&quot;, section on 'Ecthyma Gangrenosum'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mycobacterial infection &ndash; Mycobacteria associated with ulcerating lesions include <em>Mycobacterium tuberculosis</em> and <em>Mycobacterium leprae</em> infection, which may present with oral ulceronecrotic lesions. The diagnosis of mycobacterial infection is established by biopsy with evidence of acid-fast bacilli. (See <a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leprosy\" class=\"medical medical_review\">&quot;Epidemiology, microbiology, clinical manifestations, and diagnosis of leprosy&quot;</a> and <a href=\"topic.htm?path=cutaneous-manifestations-of-tuberculosis\" class=\"medical medical_review\">&quot;Cutaneous manifestations of tuberculosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mucocutaneous leishmaniasis &ndash; Mucocutaneous leishmaniasis causes disfiguring destruction of the mucous membranes of the nose and mouth; the majority of cases occur in South America. The diagnosis of leishmaniasis is established via histology or molecular techniques. (See <a href=\"topic.htm?path=cutaneous-leishmaniasis-clinical-manifestations-and-diagnosis#H83446528\" class=\"medical medical_review\">&quot;Cutaneous leishmaniasis: Clinical manifestations and diagnosis&quot;, section on 'Mucosal leishmaniasis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral and maxillofacial myiasis &ndash; Myiasis may cause a skin lesion resembling noma in adults and older children. It is caused by deposition of tumbu fly larvae in subdermal tissue [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/117\" class=\"abstract_t\">117</a>]. The diagnosis is established based on clinical manifestations and history of exposure in an area where the fly is endemic. (See <a href=\"topic.htm?path=skin-lesions-in-the-returning-traveler#H8401226\" class=\"medical medical_review\">&quot;Skin lesions in the returning traveler&quot;, section on 'Myiasis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Necrotizing fasciitis &ndash; Necrotizing fasciitis involving the head and neck typically originates from an odontogenic abscess or trauma and may be associated with gangrene of the cheek. Cervical necrotizing fasciitis typically occurs in older adults with diabetes; the diagnosis is established via surgical exploration. (See <a href=\"topic.htm?path=necrotizing-soft-tissue-infections\" class=\"medical medical_review\">&quot;Necrotizing soft tissue infections&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Osteonecrosis of the jaw &ndash; Osteonecrosis of the jaw is typically associated with medications such as bisphosphonates and generally occurs in adults in association with underlying malignancy. The diagnosis is established via radiographic imaging such as computed tomography (CT). (See <a href=\"topic.htm?path=medication-related-osteonecrosis-of-the-jaw-in-patients-with-cancer\" class=\"medical medical_review\">&quot;Medication-related osteonecrosis of the jaw in patients with cancer&quot;</a> and <a href=\"topic.htm?path=risks-of-bisphosphonate-therapy-in-patients-with-osteoporosis\" class=\"medical medical_review\">&quot;Risks of bisphosphonate therapy in patients with osteoporosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ludwig's angina &ndash; Ludwig's angina is an infection of the submandibular space that most commonly arises from an infected tooth in adults or children. The diagnosis is established based on clinical manifestations and radiographic imaging (CT scan). (See <a href=\"topic.htm?path=submandibular-space-infections-ludwigs-angina\" class=\"medical medical_review\">&quot;Submandibular space infections (Ludwig's angina)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral tumor &ndash; Tumors of the oral cavity typically present as a nonhealing ulcer or mass. The diagnosis of oral tumor is established via biopsy. (See <a href=\"topic.htm?path=oral-lesions#H2\" class=\"medical medical_review\">&quot;Oral lesions&quot;, section on 'Tumors (and lesions that mimic)'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Syphilis &ndash; In late syphilis, gummatous lesions may occur on the skin and present as ulcers or heaped-up lesions. The diagnosis of syphilis is based on serologic testing. (See <a href=\"topic.htm?path=syphilis-epidemiology-pathophysiology-and-clinical-manifestations-in-hiv-uninfected-patients#H2244594218\" class=\"medical medical_review\">&quot;Syphilis: Epidemiology, pathophysiology, and clinical manifestations in HIV-uninfected patients&quot;, section on 'Gummatous syphilis'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H17\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute treatment of noma consists of antibiotics, wound care, and replacement of needed fluids, electrolytes, and nutrition. Oral physiotherapy to relieve trismus resulting from fibrous strictures should start immediately following containment of the acute phase [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/5\" class=\"abstract_t\">5</a>]. Subsequently, surgery is performed for correction of trismus and flap creation. Oral physiotherapy is continued after surgery.</p><p>Attention to psychosocial needs is also an important component of treatment, given the cosmetic and functional debilitation associated with noma.</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Antibiotics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The optimal approach to antimicrobial therapy for treatment of noma is uncertain. The dose and type of antibiotic depend on individual circumstances and available clinical tools. Reasonable regimens include penicillin in combination with <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> or <a href=\"topic.htm?path=streptomycin-drug-information\" class=\"drug drug_general\">streptomycin</a> [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/10,27,86,118\" class=\"abstract_t\">10,27,86,118</a>]. Some favor a combination of <a href=\"topic.htm?path=amoxicillin-drug-information\" class=\"drug drug_general\">amoxicillin</a> and metronidazole; a study in the Niger Republic involving 82 patients with noma treated with this regimen noted a mortality rate of 8 percent [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/27\" class=\"abstract_t\">27</a>]. Others prefer monotherapy with metronidazole, since noma is associated predominantly with anaerobic organisms [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/11,118\" class=\"abstract_t\">11,118</a>].</p><p>For children who can swallow oral medication, antibiotics may be given in tablet or syrup form. Dosing for penicillin VK is 25 to 50 <span class=\"nowrap\">mg/kg/day</span> in three divided doses; dosing for <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> is 30 <span class=\"nowrap\">mg/kg/day</span> in three or four divided doses. For children who cannot tolerate oral medication, parenteral therapy with procaine penicillin may be administered. Dosing for procaine penicillin is 25,000 to 50,000 <span class=\"nowrap\">units/kg/day</span> in divided doses one to two <span class=\"nowrap\">times/day,</span> not to exceed 4.8 million <span class=\"nowrap\">units/24</span> hours.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Wound care</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The wound should be dressed daily with gauze soaked in antiseptic [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/10,11,30\" class=\"abstract_t\">10,11,30</a>]. If possible, the mouth should be rinsed with a solution of <a href=\"topic.htm?path=chlorhexidine-gluconate-drug-information\" class=\"drug drug_general\">chlorhexidine</a> digluconate (0.12 to 0.20%) daily [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/10,11\" class=\"abstract_t\">10,11</a>]. This may be continued for up to one week.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Fluid, electrolytes, and nutrition</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Management of acute noma requires rehydration with correction of electrolyte abnormalities followed by nutritional rehabilitation with a high protein diet enriched with essential micronutrients. At the Noma Children Hospital in Sokoto, Nigeria, a highly enriched nutrition formula (Enfortal, donated through the Dutch Noma Foundation) has yielded good results [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/63\" class=\"abstract_t\">63</a>]. Feeding by mouth is preferred. If this is not possible due to pain, tissue destruction, or severe trismus, parenteral nutrition may be administered [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,30,63\" class=\"abstract_t\">6,30,63</a>]. (See <a href=\"topic.htm?path=maintenance-fluid-therapy-in-children\" class=\"medical medical_review\">&quot;Maintenance fluid therapy in children&quot;</a> and <a href=\"topic.htm?path=oral-rehydration-therapy\" class=\"medical medical_review\">&quot;Oral rehydration therapy&quot;</a> and <a href=\"topic.htm?path=overview-of-enteral-nutrition-in-infants-and-children\" class=\"medical medical_review\">&quot;Overview of enteral nutrition in infants and children&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Surgical repair</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The goal of surgery is to improve cosmetic appearance as well as oral function including eating, drinking, swallowing, and speech [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,10,11,30,90\" class=\"abstract_t\">6,10,11,30,90</a>]. In the acute phase, intervention for control of secondary hemorrhage, removal of loose teeth, and wound debridement may be needed to prevent secondary infection and promote healing [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/77\" class=\"abstract_t\">77</a>]. To allow time for resolution of necrosis, more definitive surgery is performed several months to one year after the acute phase.</p><p>The techniques for correction of deformities depend on location and severity of the lesions, available resources, and abilities of the surgical team [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/63,90,119\" class=\"abstract_t\">63,90,119</a>]. Preoperative classification of the tissue defects is essential for planning surgical intervention (<a href=\"image.htm?imageKey=ID%2F108387\" class=\"graphic graphic_table graphicRef108387 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,10,90\" class=\"abstract_t\">6,10,90</a>]. (See <a href=\"#H8\" class=\"local\">'Clinical manifestations and diagnosis'</a> above.)</p><p>In the setting of trismus, oral physiotherapy should be initiated prior to surgery. Surgical correction of trismus requires excision of fibrous bands restricting jaw opening [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,10,30,90,118-121\" class=\"abstract_t\">6,10,30,90,118-121</a>]. Following surgery, physiotherapy is important to prevent recurrence of trismus [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/11,90,118,119\" class=\"abstract_t\">11,90,118,119</a>]. During the first few days after surgery, a bundle of wooden tongue spatulas may also be useful to help keep the mouth open.</p><p>Following management of trismus, surgical management may include tissue flaps <span class=\"nowrap\">and/or</span> bone grafting [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/5\" class=\"abstract_t\">5</a>]. Options for flap techniques range from simple flaps to complex procedures involving microsurgery [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6,90,121,122\" class=\"abstract_t\">6,90,121,122</a>].</p><p>Surgical intervention requires general anesthesia with intubation, which may be difficult in settings with limited facilities [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/90,118,123\" class=\"abstract_t\">90,118,123</a>]. Regional centers for noma surgical rehabilitation have been established in a number of developing countries, including the Noma Children Hospital (Sokoto, Nigeria), Stiftung Kinderhilfe (a German nongovernmental organization), and the Dutch Noma Foundation [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/63\" class=\"abstract_t\">63</a>]. Another organization, the German Hilfsaktion Noma, treats some cases in the Niger Republic and transfers very difficult cases to Germany.</p><p>Following surgical repair, some functional and cosmetic defects may persist. Therefore, attention to psychosocial needs is also an important component of treatment [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/118,121\" class=\"abstract_t\">118,121</a>].</p><p class=\"headingAnchor\" id=\"H67006603\"><span class=\"h2\">Other measures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The patient should undergo evaluation for predisposing systemic diseases including malaria, measles, tuberculosis, and HIV infection. In addition, routine immunizations should be administered if necessary.</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h1\">PREVENTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Prevention of noma requires a multidisciplinary approach with attention to routine healthcare needs, sanitation, nutrition, vaccination, and public awareness.</p><p>Healthcare personnel should know the risk factors for and early signs of noma and screen children at risk accordingly. The risk factors include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe growth failure in the first 6 to 12 months of life</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severe malnutrition and poor eating habits</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Persistent diarrhea</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Presence of oral mucosal ulcers</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Malodorous breath</p><p/><p>Proper oral hygiene practices must be taught and promoted. For areas in which toothbrushes and toothpaste are not available, children should be taught to use soft chewing sticks or sponges, under adult supervision. Many chewing sticks used in developing settings are fashioned from plants containing active medicinal properties; several are from the tea plant family and may concentrate fluoride from the soil [<a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/124-127\" class=\"abstract_t\">124-127</a>]. For very young children, cotton buds may substitute for chewing sticks. Saline solution is helpful for mouth rinsing.</p><p>As oral ulcers are frequently preceded by antecedent infection, administration of routine immunizations is also a priority. Other vaccines include DPT (diphtheria, pertussis, tetanus), <em>Haemophilus influenzae</em> serotype b (Hib), and polio vaccine.</p><p>Sanitation inside and outside of the residential quarters requires careful attention to the following issues:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clean drinking water must be readily available.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human waste must be removed in a timely fashion.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Livestock should be segregated from human living quarters.</p><p/><p>Adequate nutrition in the first three to six months of life is an important priority; breastfeeding should be encouraged. Weaning foods for infants should be prepared under hygienic conditions.</p><p>Noma occurs almost exclusively in resource-limited settings in which the general understanding of the causes of disease may be limited and illness may be interpreted within the framework of superstitious beliefs. Information campaigns are needed at regional and global levels.</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Noma is a severe disfiguring gangrene of the mouth and face that starts as a gingival ulcer and spreads rapidly through the tissues of the mouth and face. It is associated with poverty, malnutrition, and poor sanitation. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Noma is a polymicrobial infection associated predominantly with anaerobic organisms, although identifying a specific causative infectious agent can be difficult. <em>Fusobacterium necrophorum</em> is observed most frequently in culture and is suspected to be an important organism for the development of noma. (See <a href=\"#H2\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The incidence of noma is highest in sub-Saharan Africa; the disease also occurs in Asia and Latin America. Risk factors include poor oral hygiene, limited access to healthcare services, close residential proximity to livestock, nomadic lifestyle, and high prevalence of infectious diseases including malaria, measles, AIDS, diarrhea, and tuberculosis. Infants and children are particularly susceptible. (See <a href=\"#H3\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of noma is based on clinical manifestations. Suggestive clues include recent or concurrent infection preceding onset of facial swelling and excessive salivation in the setting of malnutrition. In general, there are three stages of noma (which may overlap): an acute phase, a gangrenous phase, and a scarring phase. (See <a href=\"#H8\" class=\"local\">'Clinical manifestations and diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute treatment consists of antibiotics, wound care, and replacement of needed fluids, electrolytes, and nutrition. We suggest treatment with penicillin or <a href=\"topic.htm?path=amoxicillin-drug-information\" class=\"drug drug_general\">amoxicillin</a>, with or without <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Dosing is as outlined above; the duration is 10 to 14 days. (See <a href=\"#H17\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Several months to one year after the acute phase, surgery is performed for correction of trismus and flap creation. Physiotherapy to reduce fibrous scarring should be initiated during the healing phase and continued after surgery. Attention to psychosocial needs is also an important component of treatment, given the cosmetic and functional debilitation associated with noma. (See <a href=\"#H17\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prevention of noma requires a multidisciplinary approach with attention to routine healthcare needs, sanitation, nutrition, and awareness. Measles immunization reduces the risk of noma. Prevention of malaria in pregnant women receiving antenatal care is also important, since placental malaria impairs transplacental transfer of maternal antibodies to the infant. (See <a href=\"#H23\" class=\"local\">'Prevention'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/1\" class=\"nounderline abstract_t\">Enwonwu CO. Noma--the ulcer of extreme poverty. N Engl J Med 2006; 354:221.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/2\" class=\"nounderline abstract_t\">Enwonwu CO. Epidemiological and biochemical studies of necrotizing ulcerative gingivitis and noma (cancrum oris) in Nigerian children. Arch Oral Biol 1972; 17:1357.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/3\" class=\"nounderline abstract_t\">Enwonwu CO, Falkler WA Jr, Phillips RS. Noma (cancrum oris). Lancet 2006; 368:147.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/4\" class=\"nounderline abstract_t\">Evrard L, Laroque G, Glineur R, Daelemans P. Noma: clinical and evolutive aspect. Acta Stomatol Belg 1996; 93:17.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/5\" class=\"nounderline abstract_t\">Ogbureke KU, Ogbureke EI. NOMA: A Preventable &quot;Scourge&quot; of African Children. Open Dent J 2010; 4:201.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/6\" class=\"nounderline abstract_t\">Tempest MN. Cancrum oris. Br J Surg 1966; 53:949.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/7\" class=\"nounderline abstract_t\">Marck KW. A history of noma, the &quot;Face of Poverty&quot;. Plast Reconstr Surg 2003; 111:1702.</a></li><li class=\"breakAll\">Boot A. Observationes Medicae de Affectibus Omissis, Thomas Newcomb, London 1649.</li><li class=\"breakAll\">Tourdes J. Du noma ou du sphacele de la bouche chez les enfants. Thesis., Strasbourg 1848.</li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/10\" class=\"nounderline abstract_t\">Baratti-Mayer D, Pittet B, Montandon D, et al. Noma: an &quot;infectious&quot; disease of unknown aetiology. Lancet Infect Dis 2003; 3:419.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/11\" class=\"nounderline abstract_t\">Van Damme PA, Sokoto noma-team 19, September 2002. Noma. Lancet Infect Dis 2004; 4:73.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/12\" class=\"nounderline abstract_t\">Leclercq MH. Can dentistry tackle inequality? The challenge of noma. FDI World 1999; 2:9.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/13\" class=\"nounderline abstract_t\">Bourgeois DM, Leclercq MH. The World Health Organization initiative on noma. Oral Dis 1999; 5:172.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/14\" class=\"nounderline abstract_t\">Weaver GH, Tunnicliff R. Noma. J Infect Dis 1907; 4:8.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/15\" class=\"nounderline abstract_t\">Falkler WA Jr, Enwonwu CO, Idigbe EO. Isolation of Fusobacterium necrophorum from cancrum oris (noma). Am J Trop Med Hyg 1999; 60:150.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/16\" class=\"nounderline abstract_t\">Falkler WA, Enwonwu CO, Ewell AJ, Idigbe EO. Isolation of fusobacteria from the oral cavities of malnourished Nigerian children living in agricultural and herding villages. Oral Dis 2000; 6:103.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/17\" class=\"nounderline abstract_t\">Phillips RS, Enwonwu CO, Falkler WA. Pro- versus anti-inflammatory cytokine profile in African children with acute oro-facial noma (cancrum oris, noma). Eur Cytokine Netw 2005; 16:70.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/18\" class=\"nounderline abstract_t\">Enwonwu CO, Falkler WA, Idigbe EO. Oro-facial gangrene (noma/cancrum oris): pathogenetic mechanisms. Crit Rev Oral Biol Med 2000; 11:159.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/19\" class=\"nounderline abstract_t\">Hack CE, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997; 66:101.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/20\" class=\"nounderline abstract_t\">Rotbart HA, Levin MJ, Jones JF, et al. Noma in children with severe combined immunodeficiency. J Pediatr 1986; 109:596.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/21\" class=\"nounderline abstract_t\">Falkler WA Jr, Enwonwu CO, Idigbe EO. Microbiological understandings and mysteries of noma (cancrum oris). Oral Dis 1999; 5:150.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/22\" class=\"nounderline abstract_t\">Vaidyanathan S, Tullu MS, Lahiri KR, Deshmukh CT. Pseudomonas sepsis with Noma: an association? Indian J Med Sci 2005; 59:357.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/23\" class=\"nounderline abstract_t\">Paster BJ, Falkler Jr WA Jr, Enwonwu CO, et al. Prevalent bacterial species and novel phylotypes in advanced noma lesions. J Clin Microbiol 2002; 40:2187.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/24\" class=\"nounderline abstract_t\">Contreras A, Falkler WA Jr, Enwonwu CO, et al. Human Herpesviridae in acute necrotizing ulcerative gingivitis in children in Nigeria. Oral Microbiol Immunol 1997; 12:259.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/25\" class=\"nounderline abstract_t\">Ko&#378;mi&#324;ska-Kubarska A, Talleyrand D, Bakatubia M. Cutaneous complications during measles in Zairian children: noma-like postmeasles ulcerations. Int J Dermatol 1982; 21:465.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/26\" class=\"nounderline abstract_t\">Horning GM. Necotizing gingivostomatitis: NUG to noma. Compend Contin Educ Dent 1996; 17:951.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/27\" class=\"nounderline abstract_t\">Baratti-Mayer D, Gayet-Ageron A, Hugonnet S, et al. Risk factors for noma disease: a 6-year, prospective, matched case-control study in Niger. Lancet Glob Health 2013; 1:e87.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/28\" class=\"nounderline abstract_t\">Bolivar I, Whiteson K, Stadelmann B, et al. Bacterial diversity in oral samples of children in niger with acute noma, acute necrotizing gingivitis, and healthy controls. PLoS Negl Trop Dis 2012; 6:e1556.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/29\" class=\"nounderline abstract_t\">Barmes DE, Enwonwu CO, Leclercq MH, et al. The need for action against oro-facial gangrene (noma). Trop Med Int Health 1997; 2:1111.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/30\" class=\"nounderline abstract_t\">Adolph HP, Yugueros P, Woods JE. Noma: a review. Ann Plast Surg 1996; 37:657.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/31\" class=\"nounderline abstract_t\">Enwonwu CO, Falkler WA Jr, Idigbe EO, et al. Pathogenesis of cancrum oris (noma): confounding interactions of malnutrition with infection. Am J Trop Med Hyg 1999; 60:223.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/32\" class=\"nounderline abstract_t\">Srour ML, Watt B, Phengdy B, et al. Noma in Laos: stigma of severe poverty in rural Asia. Am J Trop Med Hyg 2008; 78:539.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/33\" class=\"nounderline abstract_t\">Jim&eacute;nez LM, Duque FL, Baer PN, Jim&eacute;nez SB. Necrotizing ulcerative periodontal diseases in children and young adults in Medell&iacute;n, Colombia, 1965--2000. J Int Acad Periodontol 2005; 7:55.</a></li><li class=\"breakAll\">World Health Organization. World Health Report, 1998, Geneva: WHO, 1998.</li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/35\" class=\"nounderline abstract_t\">Bickler SW, Sanno-Duanda B. Epidemiology of paediatric surgical admissions to a government referral hospital in the Gambia. Bull World Health Organ 2000; 78:1330.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/36\" class=\"nounderline abstract_t\">Bourgeois DM, Diallo B, Frieh C, Leclercq MH. Epidemiology of the incidence of oro-facial noma: a study of cases in Dakar, Senegal, 1981-1993. Am J Trop Med Hyg 1999; 61:909.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/37\" class=\"nounderline abstract_t\">Enwonwu CO, Phillips RS, Ferrell CD. Temporal relationship between the occurrence of fresh noma and the timing of linear growth retardation in Nigerian children. Trop Med Int Health 2005; 10:65.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/38\" class=\"nounderline abstract_t\">Costini B, Larroque G, Duboscq JC, Montandon D. [Noma or cancrum oris: etiopathogenic and nosologic aspects]. Med Trop (Mars) 1995; 55:263.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/39\" class=\"nounderline abstract_t\">Yuca K, Yuca SA, Cankaya H, et al. Report of an infant with noma (cancrum oris). J Dermatol 2004; 31:488.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/40\" class=\"nounderline abstract_t\">Chidzonga MM, Mahomva L. Noma (cancrum oris) in human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV and AIDS): clinical experience in Zimbabwe. J Oral Maxillofac Surg 2008; 66:475.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/41\" class=\"nounderline abstract_t\">ADELSBERGER L. Medical observations in Auschwitz concentration camp. Lancet 1946; 1:317.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/42\" class=\"nounderline abstract_t\">Dawson J. Cancrum oris. Br Dent J 1945; 79:151.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/43\" class=\"nounderline abstract_t\">Idigbe EO, Enwonwu CO, Falkler WA, et al. Living conditions of children at risk for noma: Nigerian experience. Oral Dis 1999; 5:156.</a></li><li class=\"breakAll\">Cunningham-Rundles S, McNeely D, Ananworanich JM. Immune response in malnutrition. In: Immunologic Disorders in Infants and Children, 5th ed, Stiehm ER, Ochs HD, Winkelstein JA (Eds), Elsevier Saunders, Philadelphia 2004. p.761.</li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/45\" class=\"nounderline abstract_t\">Prentice AM, Gershwin ME, Schaible UE, et al. New challenges in studying nutrition-disease interactions in the developing world. J Clin Invest 2008; 118:1322.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/46\" class=\"nounderline abstract_t\">Sawyer DR, Nwoku AL, Rotimi VO, Hagen JC. Comparison of oral microflora between well-nourished and malnourished Nigerian children. ASDC J Dent Child 1986; 53:439.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/47\" class=\"nounderline abstract_t\">Cunningham-Rundles S, Lin H, Ho-Lin D, et al. Role of nutrients in the development of neonatal immune response. Nutr Rev 2009; 67 Suppl 2:S152.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/48\" class=\"nounderline abstract_t\">Dylewski ML, Mastro AM, Picciano MF. Maternal selenium nutrition and neonatal immune system development. Biol Neonate 2002; 82:122.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/49\" class=\"nounderline abstract_t\">Rahman MJ, Sarker P, Roy SK, et al. Effects of zinc supplementation as adjunct therapy on the systemic immune responses in shigellosis. Am J Clin Nutr 2005; 81:495.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/50\" class=\"nounderline abstract_t\">Long KZ, Santos JI, Rosado JL, et al. Impact of vitamin A on selected gastrointestinal pathogen infections and associated diarrheal episodes among children in Mexico City, Mexico. J Infect Dis 2006; 194:1217.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/51\" class=\"nounderline abstract_t\">Rehan NE, Tafida DS. Low birthweight in Hausa infants. Niger J Paediatr 1981; 8:35.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/52\" class=\"nounderline abstract_t\">Ransome-Kuti O. Intra-uterine growth, birthweights and maturity of the African newborn. Acta Paediatr Scand Suppl 1985; 319:95.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/53\" class=\"nounderline abstract_t\">Rowland RW. Necrotizing ulcerative gingivitis. Ann Periodontol 1999; 4:65.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/54\" class=\"nounderline abstract_t\">L&oacute;pez R, Baelum V. Necrotizing ulcerative gingival lesions and clinical attachment loss. Eur J Oral Sci 2004; 112:105.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/55\" class=\"nounderline abstract_t\">Enwonwu CO, Phillips RS, Savage KO. Inflammatory cytokine profile and circulating cortisol levels in malnourished children with necrotizing ulcerative gingivitis. Eur Cytokine Netw 2005; 16:240.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/56\" class=\"nounderline abstract_t\">Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 1993; 22:289.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/57\" class=\"nounderline abstract_t\">Contreras A, Slots J. Herpesviruses in human periodontal disease. J Periodontal Res 2000; 35:3.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/58\" class=\"nounderline abstract_t\">Sabiston CB Jr. A review and proposal for the etiology of acute necrotizing gingivitis. J Clin Periodontol 1986; 13:727.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/59\" class=\"nounderline abstract_t\">Whiteson KL, Lazarevic V, Tangomo-Bento M, et al. Noma affected children from Niger have distinct oral microbial communities based on high-throughput sequencing of 16S rRNA gene fragments. PLoS Negl Trop Dis 2014; 8:e3240.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/60\" class=\"nounderline abstract_t\">Naniche D. Generalized immunosuppression: individual viruses, intertwined targets. Virology 2000; 275:227.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/61\" class=\"nounderline abstract_t\">Phillips RS, Enwonwu CO, Okolo S, Hassan A. Metabolic effects of acute measles in chronically malnourished Nigerian children. J Nutr Biochem 2004; 15:281.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/62\" class=\"nounderline abstract_t\">Atabani SF, Byrnes AA, Jaye A, et al. Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 2001; 184:1.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/63\" class=\"nounderline abstract_t\">Marck KW, Spijkervet FK. [Noma: 'the face of poverty']. Ned Tijdschr Tandheelkd 2001; 108:496.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/64\" class=\"nounderline abstract_t\">Whittle HC, Smith JS, Kogbe OI, et al. Severe ulcerative herpes of mouth and eye following measles. Trans R Soc Trop Med Hyg 1979; 73:66.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/65\" class=\"nounderline abstract_t\">Mina MJ, Metcalf CJ, de Swart RL, et al. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 2015; 348:694.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/66\" class=\"nounderline abstract_t\">Emslie RD. Cancrum oris. Dent Pract Dent Rec 1963; 13:481.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/67\" class=\"nounderline abstract_t\">Dossetor J, Whittle HC, Greenwood BM. Persistent measles infection in malnourished children. Br Med J 1977; 1:1633.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/68\" class=\"nounderline abstract_t\">Eckstein A. Noma. Am J Dis Child 1940; 59:219.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/69\" class=\"nounderline abstract_t\">Enwere GC, Ota MO, Obaro SK. The host response in malaria and depression of defence against tuberculosis. Ann Trop Med Parasitol 1999; 93:669.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/70\" class=\"nounderline abstract_t\">Lyke KE, Burges R, Cissoko Y, et al. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 2004; 72:5630.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/71\" class=\"nounderline abstract_t\">Shio MT, Eisenbarth SC, Savaria M, et al. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 2009; 5:e1000559.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/72\" class=\"nounderline abstract_t\">Clark IA, Budd AC, Alleva LM, Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malar J 2006; 5:85.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/73\" class=\"nounderline abstract_t\">van den Berg JP, Westerbeek EA, van der Klis FR, et al. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev 2011; 87:67.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/74\" class=\"nounderline abstract_t\">Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/75\" class=\"nounderline abstract_t\">Walther B, Miles DJ, Crozier S, et al. Placental malaria is associated with reduced early life weight development of affected children independent of low birth weight. Malar J 2010; 9:16.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/76\" class=\"nounderline abstract_t\">Rachas A, Le Port A, Cottrell G, et al. Placental malaria is associated with increased risk of nonmalaria infection during the first 18 months of life in a Beninese population. Clin Infect Dis 2012; 55:672.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/77\" class=\"nounderline abstract_t\">Nath S, Jovic G. Cancrum oris: management, incidence, and implications of human immunodeficiency virus in Zambia. Plast Reconstr Surg 1998; 102:350.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/78\" class=\"nounderline abstract_t\">Adedoja D, Kabue MM, Sahila P. Cancrum oris in HIV infected children in Lesotho: report of two cases. East Afr Med J 2002; 79:499.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/79\" class=\"nounderline abstract_t\">Naidoo S, Chikte UM. Noma (cancrum oris): case report in a 4-year-old HIV-positive South African child. SADJ 2000; 55:683.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/80\" class=\"nounderline abstract_t\">Evans LM, Lane H, Jones MK. Cancrum oris in a Caucasian male with Type 2 diabetes mellitus. Diabet Med 2001; 18:246.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/81\" class=\"nounderline abstract_t\">Elazary AS, Lador N, Shauer A, et al. Tongue necrosis and pericarditis. Lancet 2004; 363:948.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/82\" class=\"nounderline abstract_t\">Kirstil&auml; V, Sew&oacute;n L, Laine J. Periodontal disease in three siblings with familial neutropenia. J Periodontol 1993; 64:566.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/83\" class=\"nounderline abstract_t\">Watanabe H, Goseki-Sone M, Iimura T, et al. Molecular diagnosis of hypophosphatasia with severe periodontitis. J Periodontol 1999; 70:688.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/84\" class=\"nounderline abstract_t\">Kwong PC, O'Marcaigh AS, Howard R, et al. Oral and genital ulceration: a unique presentation of immunodeficiency in Athabascan-speaking American Indian children with severe combined immunodeficiency. Arch Dermatol 1999; 135:927.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/85\" class=\"nounderline abstract_t\">Meyle J, Gonz&aacute;les JR. Influences of systemic diseases on periodontitis in children and adolescents. Periodontol 2000 2001; 26:92.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/86\" class=\"nounderline abstract_t\">Limongelli WA, Clark MS, Williams AC. Nomalike lesion in a patient with chronic lymphocytic leukemia. Review of the literature and report of a case. Oral Surg Oral Med Oral Pathol 1976; 41:40.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/87\" class=\"nounderline abstract_t\">Berthold P. Noma: a forgotten disease. Dent Clin North Am 2003; 47:559.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/88\" class=\"nounderline abstract_t\">Enwonwu CO, Phillips RS, Ibrahim CD, Danfillo IS. Nutrition and oral health in Africa. Int Dent J 2004; 54:344.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/89\" class=\"nounderline abstract_t\">Fasola AO, Obiechina AE, Arotiba JT. Unusual presentation of NOMA: a case report. Afr J Med Med Sci 2003; 32:417.</a></li><li class=\"breakAll\">Bos K, Marck K. The Surgical treatment of noma, Uitgeverij Belv&eacute;dere/Medidact, Alphen aan den Rijn, The Netherlands 2006.</li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/91\" class=\"nounderline abstract_t\">Beisel WR. Nutrition in pediatric HIV infection: setting the research agenda. Nutrition and immune function: overview. J Nutr 1996; 126:2611S.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/92\" class=\"nounderline abstract_t\">Enwonwu CO, Ritchie CS. Nutrition and inflammatory markers. J Am Dent Assoc 2007; 138:70.</a></li><li class=\"breakAll\">Enwonwu CO. Vitamin supplements and oral health. In: Food Constituents and Oral Health. Current Status and Future Prospects, Wilson M (Ed), Woodhead Publishing Ltd., Oxford 2009. p.298.</li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/94\" class=\"nounderline abstract_t\">Gruver AL, Sempowski GD. Cytokines, leptin, and stress-induced thymic atrophy. J Leukoc Biol 2008; 84:915.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/95\" class=\"nounderline abstract_t\">Savino W, Dardenne M, Velloso LA, Dayse Silva-Barbosa S. The thymus is a common target in malnutrition and infection. Br J Nutr 2007; 98 Suppl 1:S11.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/96\" class=\"nounderline abstract_t\">Slomiany BL, Slomiany A. Role of leptin in modulation of Porphyromonas gingivalis lipopolysaccharide-induced up-regulation of endothelin-1 in salivary gland acinar cells. IUBMB Life 2005; 57:591.</a></li><li class=\"breakAll\">Enwonwu CO, Unpublished data.</li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/98\" class=\"nounderline abstract_t\">van Crevel R, Karyadi E, Netea MG, et al. Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation. J Clin Endocrinol Metab 2002; 87:758.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/99\" class=\"nounderline abstract_t\">Steinberg MW, Turovskaya O, Shaikh RB, et al. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med 2008; 205:1463.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/100\" class=\"nounderline abstract_t\">Cai G, Freeman GJ. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev 2009; 229:244.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/101\" class=\"nounderline abstract_t\">Cheung TC. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway. Recent Pat DNA Gene Seq 2009; 3:177.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/102\" class=\"nounderline abstract_t\">Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med (Berl) 2002; 80:147.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/103\" class=\"nounderline abstract_t\">Kashiwamura S, Ueda H, Okamura H. Roles of interleukin-18 in tissue destruction and compensatory reactions. J Immunother 2002; 25 Suppl 1:S4.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/104\" class=\"nounderline abstract_t\">Eaton AD, Xu D, Garside P. Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology 2003; 108:196.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/105\" class=\"nounderline abstract_t\">Ishikura T, Kanai T, Uraushihara K, et al. Interleukin-18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin-18 transgenic mice. J Gastroenterol Hepatol 2003; 18:960.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/106\" class=\"nounderline abstract_t\">Okada H, Sato TA, Katayama A, et al. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines. Arch Virol 2001; 146:859.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/107\" class=\"nounderline abstract_t\">Nagamine Y, Hayano M, Kashiwamura S, et al. Involvement of interleukin-18 in severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 2003; 97:236.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/108\" class=\"nounderline abstract_t\">Oberholzer A, Steckholzer U, Kurimoto M, et al. Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients. Shock 2001; 16:411.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/109\" class=\"nounderline abstract_t\">Brandtzaeg P. Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta Odontol Scand 2001; 59:235.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/110\" class=\"nounderline abstract_t\">Church J, Maitland K. Invasive bacterial co-infection in African children with Plasmodium falciparum malaria: a systematic review. BMC Med 2014; 12:31.</a></li><li class=\"breakAll\">Mead S. Oral Surgery, The C.V. Mosby Company, St. Louis 1946.</li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/112\" class=\"nounderline abstract_t\">Eisele DW, Inglis AF Jr, Richardson MA. Noma and noma neonatorum. Ear Nose Throat J 1990; 69:119.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/113\" class=\"nounderline abstract_t\">Juster-Reicher A, Mogilner BM, Levi G, et al. Neonatal noma. Am J Perinatol 1993; 10:409.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/114\" class=\"nounderline abstract_t\">Atiyeh BS, Hashim HA, Rubeiz MT, et al. Necrotising infection of the orofacial tissues in neonates (noma neonatorum). Case report. Scand J Plast Reconstr Surg Hand Surg 1998; 32:343.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/115\" class=\"nounderline abstract_t\">Parikh TB, Nanavati RN, Udani RH. Noma neonatorum. Indian J Pediatr 2006; 73:439.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/116\" class=\"nounderline abstract_t\">Freeman AF, Mancini AJ, Yogev R. Is noma neonatorum a presentation of ecthyma gangrenosum in the newborn? Pediatr Infect Dis J 2002; 21:83.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/117\" class=\"nounderline abstract_t\">Aguiar AM, Enwonwu CO, Pires FR. Noma (cancrum oris) associated with oral myiasis in an adult. Oral Dis 2003; 9:158.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/118\" class=\"nounderline abstract_t\">Adekeye EO, Ord RA. Cancrum oris: principles of management and reconstructive surgery. J Maxillofac Surg 1983; 11:160.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/119\" class=\"nounderline abstract_t\">Pittet B, Jaquinet A, Montandon D. Clinical experience in the treatment of noma sequelae. J Craniofac Surg 2001; 12:273.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/120\" class=\"nounderline abstract_t\">Giessler GA, Schmidt AB. Noma: experiences with a microvascular approach under West African conditions. Plast Reconstr Surg 2003; 112:947.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/121\" class=\"nounderline abstract_t\">Hartman EH, Van Damme PA, Sauter H, Suominen SH. The use of the pedicled supraclavicular flap in noma reconstructive surgery. J Plast Reconstr Aesthet Surg 2006; 59:337.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/122\" class=\"nounderline abstract_t\">Thiery G, Liard O, Duboscq JC. [Treatment of noma]. Med Trop (Mars) 2002; 62:193.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/123\" class=\"nounderline abstract_t\">Tassonyi E, Lehmann C, Gunning K, et al. Fiberoptically guided intubation in children with gangrenous stomatitis (noma). Anesthesiology 1990; 73:348.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/124\" class=\"nounderline abstract_t\">Enwonwu CO. Societal expectations for oral health: response of the dental care system in Africa. J Public Health Dent 1988; 48:84.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/125\" class=\"nounderline abstract_t\">Elvin-Lewis M. Plants used for teeth cleaning throughout the world. J Prev Dent 1980; 6:61.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/126\" class=\"nounderline abstract_t\">Rai K, Agarwal M, Dass S, Shrivastay R. Fluoride: Diffusive mobility in soil and some remedial measures to control its plant uptake. Curr Sci 2000; 79:1370.</a></li><li><a href=\"https://www.uptodate.com/contents/noma-cancrum-oris/abstract/127\" class=\"nounderline abstract_t\">Ruan J, Ma L, Shi Y, H W. Uptake of fluoride by tea plant (Camellia sinensis L). J Sci Food Acric 83:1342.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3037 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H24\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MICROBIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">EPIDEMIOLOGY</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Risk factors</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">- Malnutrition</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">- Acute necrotizing gingivitis</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Other factors</a></li></ul></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">CLINICAL MANIFESTATIONS AND DIAGNOSIS</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">Acute phase</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Gangrenous phase</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Scarring phase</a></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">PATHOGENESIS</a><ul><li><a href=\"#H13\" id=\"outline-link-H13\">Histopathology</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Role of malnutrition</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">Inflammatory mediators</a></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">TREATMENT</a><ul><li><a href=\"#H18\" id=\"outline-link-H18\">Antibiotics</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Wound care</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Fluid, electrolytes, and nutrition</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Surgical repair</a></li><li><a href=\"#H67006603\" id=\"outline-link-H67006603\">Other measures</a></li></ul></li><li><a href=\"#H23\" id=\"outline-link-H23\">PREVENTION</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3037|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/70829\" class=\"graphic graphic_picture\">- Noma lesion</a></li><li><a href=\"image.htm?imageKey=ID/64614\" class=\"graphic graphic_picture\">- Necrotizing gingivitis</a></li><li><a href=\"image.htm?imageKey=ID/62639\" class=\"graphic graphic_picture\">- Child with severe Noma</a></li></ul></li><li><div id=\"ID/3037|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/108387\" class=\"graphic graphic_table\">- NOITULP classification Noma facial defects</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=cutaneous-leishmaniasis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Cutaneous leishmaniasis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cutaneous-manifestations-of-tuberculosis\" class=\"medical medical_review\">Cutaneous manifestations of tuberculosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leprosy\" class=\"medical medical_review\">Epidemiology, microbiology, clinical manifestations, and diagnosis of leprosy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=maintenance-fluid-therapy-in-children\" class=\"medical medical_review\">Maintenance fluid therapy in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=medication-related-osteonecrosis-of-the-jaw-in-patients-with-cancer\" class=\"medical medical_review\">Medication-related osteonecrosis of the jaw in patients with cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=necrotizing-soft-tissue-infections\" class=\"medical medical_review\">Necrotizing soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=oral-lesions\" class=\"medical medical_review\">Oral lesions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=oral-rehydration-therapy\" class=\"medical medical_review\">Oral rehydration therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-enteral-nutrition-in-infants-and-children\" class=\"medical medical_review\">Overview of enteral nutrition in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=periodontal-disease-in-children-associated-systemic-conditions\" class=\"medical medical_review\">Periodontal disease in children: Associated systemic conditions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pseudomonas-aeruginosa-skin-and-soft-tissue-infections\" class=\"medical medical_review\">Pseudomonas aeruginosa skin and soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=risks-of-bisphosphonate-therapy-in-patients-with-osteoporosis\" class=\"medical medical_review\">Risks of bisphosphonate therapy in patients with osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=skin-lesions-in-the-returning-traveler\" class=\"medical medical_review\">Skin lesions in the returning traveler</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=submandibular-space-infections-ludwigs-angina\" class=\"medical medical_review\">Submandibular space infections (Ludwig's angina)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=syphilis-epidemiology-pathophysiology-and-clinical-manifestations-in-hiv-uninfected-patients\" class=\"medical medical_review\">Syphilis: Epidemiology, pathophysiology, and clinical manifestations in HIV-uninfected patients</a></li></ul></div></div>","javascript":null}